SCHEMBL96565

SCHEMBL96565

[CH2]c1ccc(NS(=O)(=O)c2c(F)cccc2F)cc1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.66
SLC40A1 Q9NP59 2/20 0.44
CA1 P00915 6/20 0.44
CA2 P00918 6/20 0.44
ALDH1A1 P00352 3/20 0.43
ATM Q13315 1/20 0.40
KMT2A Q03164 2/20 0.39
MAPT P10636 2/20 0.39
GAA P10253 2/20 0.39
GFER P55789 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.38
BRD4 O60885 1/20 0.38
PKLR P30613 1/20 0.38
FFAR4 Q5NUL3 1/20 0.37
IL1RN P18510 1/20 0.37
KEAP1 Q14145 1/20 0.37
ERAP1 Q9NZ08 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7572618 0.85 PKM (0.70) PKMSLC40A1CA1CA2ALDH1A1
SCHEMBL7579145 0.83 PKM (0.83) PKMSLC40A1CA1CA2ALDH1A1
SCHEMBL7569548 0.82 PKM (0.66) PKMSLC40A1CA1CA2ALDH1A1
SCHEMBL97052 0.81 ALDH1A1 (0.65) PKMALDH1A1ATMKMT2AMAPT
SCHEMBL132296 0.79 ATM (0.62) PKMSLC40A1ALDH1A1ATMKMT2A
SCHEMBL7580419 0.78 PKM (0.60) PKMSLC40A1CA1CA2BRD4
SCHEMBL14058523 0.77 MAPT (0.60) PKMALDH1A1ATMKMT2AMAPT
SCHEMBL7572729 0.75 PKM (0.56) PKMALDH1A1KMT2AMAPTGAA
SCHEMBL17340525 0.75 PKM (0.56) PKMCA1CA2ALDH1A1ATM
SCHEMBL95797 0.75 PGR (0.65) PKMATMKMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB PKM 3397/4885SLC40A1 2377/4885CA1 3276/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 PKM 2789/4885SLC40A1 1044/4885CA1 2592/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 PKM 2789/4885SLC40A1 1044/4885CA1 2592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.